Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas

BMC Clinical Pathology

Table 3 Expression of markers in peritumoral capsule and their prediction for disease-specific survival in patients with soft tissue sarcomas (univariate analysis; log-rank test), N = 80

Marker expression	Patients (n)	Patients (%)	Median survival (months)	5-Year survival (%)	P
CD 57
Low	50	63	38	47	0.797
High	29	36	123	55
Missing	1	1
CD 68
Low	34	43	NR	61	0.057
High	45	56	31	43
Missing	1	1
M-CSF
Low	36	45	75	54	0.608
High	39	49	36	46
Missing	5	6
CSF-1R
Low	36	45	52	49	0.587
High	37	46	57	47
Missing	7	9
Ki67
Low	32	40	NR	74	<0.001
High	37	46	29	35
Missing	11	14
TGF-beta
Low	43	54	52	50	0.906
High	28	35	31	50
Missing	9	11
M-CSF and TGF-beta
Low	24	30	80	57	0.626
High	42	53	31	45
Missing	14	18

ISSN: 1472-6890